Home Market Volatility Leaves Behind Bargain Cancer Biotech - Adaptimmune
 

Keywords :   


Market Volatility Leaves Behind Bargain Cancer Biotech - Adaptimmune

2015-09-10 20:44:16| Biotech - Topix.net

Adaptimmune just hit its all-time low on the NASDAQ after closing just above $11 per share. Since offering shares in early May, the company has traded largely in the $14.50-$15.50 price range.

Tags: market cancer leaves bargain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
02.07Ecolab Launches 100% Plastic-Free Wipe for Healthcare Settings
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
More »